Corporate Profile
Our Business
We are in the business of:
- Research, development, production and sale of pharmaceutical
drugs for the fields of orthopaedics, neurology, gastroenterology
and hepatology, focusing on natural drugs and chemical drugs with
new formulations
- Distribution of products of other pharmaceutical manufacturers
in the PRC
- Processing and sale of active ingredients, mainly chondroition
sulphate, for the manufacture of pharmaceutical drugs
- Sale of R&D results and/or patents of new drugs and provision
of research services on a contract basis
Drugs with new formulations refer to drugs with different pharmaceutical
product type but containing the same active ingredient as included
in an existing drug. Such pharmaceutical product types include drugs
with different administration forms (for example, oral to injection),
new delivery systems (for example, modified release tablets such
as immediate, sustained and controlled released tablets) and different
dosage forms with the same administration method. Drugs with new
formulations are convenient to use, have greater efficacy and reduced
side effects.
Our principal business is in the PRC. Our operating subsidiary,
Shandong Luye, first obtained the Pharmaceutical Production Enterprise
Licence on 6 June 1994 from the Shandong Health Bureau and obtained
a replacement National Pharmaceutical Production Licence on 20 May
2001. Our trading subsidiary, Luye Drugs Trading obtained the Pharmaceutical
Trading Enterprise Licence on 18 February 1997 and the National
GSP certification on 1 December 2003. Since we commenced operations,
the licences have been renewed upon expiry and none have been revoked
or terminated.
Our Products and Services
Currently, we manufacture and sell a wide range of products in
various forms and specifications. As at 27 April 2004, we have obtained
manufacturing permits for a total of 19 drugs comprising 17 prescription
drugs and two OTC drugs. Currently, we manufacture and sell ten
of these 19 drugs, eight of which are prescription drugs and two
are OTC drugs. We also export four main active ingredients such
as chondroitin sulphate for the manufacture of pharmaceutical drugs.
Our Main Products
  
- Maitongna (Sodium Aescinate for Injection) is an anti-inflammatory
and anti-swelling drug mainly used in the fields of orthopaedics
and neurology to treat inflammation and swelling resulting from
causes such as hydrocephalus, intracephalic hematoma, chronic
venous insufficiency, burns, traumas, fractures and wounds.
- Nuosen (Sodium Pantoprazole for Injection) is a prescription
drug, principally used for the treatment of gastroenterological
ailments such as duodenum ulcers, gastric ulcers, acute pathologic
change of gastric mucosa, compound gastric ulcer and acute haemorrhage
of the upper digestive tract.
- Lutingnuo (Reduced Glutathione for Injection) is a prescription
drug, principally used in the field of hepatology for the treatment
of liver ailments such as acute alcoholic hepatitis, alcoholic
hepatic fibrosis and liver cirrhosis. It also reduces toxins from
chemical treatments on tumour patients.
- Olai (Compound Sodium Aescinate Gel) is principally used for
pain relief and anti-inflammatory purposes caused by dropsy and
maematoma. It also relieves symptoms to the veins caused by vein
transfusion and phlebitis in order to maintain the normal functions
of the veins.
Drugs That We Distribute
We distribute drugs of other pharmaceutical manufacturers mainly
in Yantai, Shandong through our trading subsidiary, Yantai Luye
Drugs Trading Co., Ltd. The main products distributed in FY2003
were Di Sai Zhen, Dianeal®PD-2 peritoneal dialysis solution,
Hua Hong Tablets, Elcatonin for Injection, Xian Kang and Xian Shu.
Processing and Sale of Active Ingredients
We process and sell active ingredients for the manufacture of pharmaceutical
drugs, mainly chondroitin sulphate.
Sale of R&D Results and/or Patents
We provide contract research services, sell our R&D results
and/or patents of new drugs to other pharmaceutical manufacturers.
|
